Kukje Pharma Co Ltd (002720.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7002720001
Kukje Pharma Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 156.46 bn KRW | 175.50 bn KRW |
| Gross profit | 82.50 bn KRW | 93.64 bn KRW |
| Operating income | 6.70 bn KRW | 6.18 bn KRW |
| EBIT | 7.82 bn KRW | 7.35 bn KRW |
| Net income | 5.21 bn KRW | 5.70 bn KRW |
| Diluted EPS – continuing operations | 255.63 KRW | 269.27 KRW |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kukje Pharma Co Ltd
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.
More stocks
- Sensys Gatso Group AB (SGG.ST)
- Nam Liong Global Corp (5450.TWO)
- Aplisens SA (APN.WA)
- ROK Resources Inc (ROK.V)
- K Auction Inc. (102370.KQ)
- Petros Petropoulos AEBE (PETRO.AT)
- Xavi Technologies Corp. (3447.TW)
- BTCS Inc. (BTCS)
- Kentucky First Federal Bancorp (KFFB)
- JMC Electronics Co Ltd (6552.TW)
- XIIlab Co. Ltd. (189330.KQ)
- Koryo Electronics Co Ltd (8032.TWO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.